Novo Nordisk Recalls Victoza Injection Due to Temperature Abuse
Novo Nordisk is recalling specific lots of Victoza (liraglutide) injection because they were stored below 32°F, potentially causing loss of efficacy and device damage.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves potential lack of efficacy and device damage due to storage errors, which fits the criteria for moderate severity without reported injuries or deaths.
Plain-English summary
Novo Nordisk Inc is recalling specific lots of Victoza (liraglutide) injection, 18 mg/3 mL (6 mg/mL). The affected products include the Victoza Pen and Kit, identified by lot codes I2419A (Kit) and JS68K86 (Pen), with an expiration date of 05/31/2021. The recall is due to temperature abuse, where product samples were stored at temperatures below 32°F, which does not meet storage requirements.
This temperature deviation could cause a lack of efficacy in the medication and damage to the cartridge and pen-injectors. The affected products were distributed nationwide in the USA. The agency has classified this recall as Class II.
Consumers and healthcare providers should check their Victoza products for the specific lot codes and expiration date listed above. If the product matches the recalled description, it should not be used. Patients should contact their healthcare provider for guidance on alternative treatment options or replacement products.
The recalled product
- Product
- VICTOZA (LIRAGLUTIDE)
- Brand
- VICTOZA
- Manufacturer
- Novo Nordisk Inc
- Category
- Drug — Prescription Injection
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- I2419A (Kit)
- JS68K86 (Pen) exp 05/31/2021
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 13 recalled by Novo Nordisk Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same manufacturer · Novo Nordisk Inc
See all →- HighWegovy 0.5 mg pens recalled after hair was found in a syringe
FDA (Drugs) · 2026-01-07
- HighWegovy prefilled pens recalled after hair was found in a syringe
FDA (Drugs) · 2026-01-07
- ModerateNovo Nordisk Recalls Saxenda Injection Samples Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- SevereNovo Nordisk Recalls Fiasp Insulin Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- SevereNovo Nordisk Recalls Insulin Diluting Medium Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
Same hazard · lack of efficacy
See all →- SevereNovo Nordisk Recalls Fiasp Insulin Pens Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- ModerateNovo Nordisk Recalls OZEMPIC Injection Pens Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- SevereNovo Nordisk Recalls TRESIBA Insulin Pens Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- SevereNovo Nordisk Recalls TRESIBA Insulin Samples Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- SevereNovo Nordisk Recalls TRESIBA Insulin Pens Due to Temperature Abuse
FDA (Drugs) · 2021-04-21